SMG240621P75000
- 12.45
- 0.000.00%
The Scotts Miracle Newsroom
Scotts Miracle-Gro (NYSE:SMG) May Have Issues Allocating Its Capital
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in trouble. A business that's potentially in decline often shows two trends, a retu
Here's What's Concerning About Scotts Miracle-Gro's (NYSE:SMG) Returns On Capital
Scotts Miracle-Gro Reaffirms $1B Cash Flow Target, Reduces EBITDA Earnings Expectations, Cost-Saving On Track
The Scotts Miracle-Gro Company (NYSE:SMG) updated and reduced its financial projections on Thursday for fiscal year 2024 based on financial results through the end of May, which reflects the peak of i
Wells Fargo Maintains The Scotts Miracle(SMG.US) With Buy Rating, Maintains Target Price $83
Wells Fargo analyst Christopher Carey maintains $The Scotts Miracle(SMG.US)$ with a buy rating, and maintains the target price at $83.According to TipRanks data, the analyst has a success rate of 56.1
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 6, 2024
GAINERS:MJ Holdings (OTC:MJNE) shares closed up 50.94% at $0.01Global Hemp Group (OTC:GBHPF) shares closed up 33.33% at $0.04CNBX Pharmaceuticals (OTC:CNBX) shares closed up 17.69% at $0.011933 Indust
Scotts Miracle-Gro Slides After Lowering Full-year Adjusted EBITDA Outlook
Scotts Miracle-Gro Lowers Adjusted EBITDA Guidance for Fiscal 2024
Scotts Miracle-Gro (SMG) said Thursday it now expects its fiscal year 2024 non-GAAP adjusted earnings before interest, taxes, depreciation, and amortization in the range of $530 million to $540 millio
ScottsMiracle-Gro Now Sees Non-GAAP Adj. EBITDA $530M-$540M Vs Prior Guidance Of $575M
ScottsMiracle-Gro Now Sees Non-GAAP Adj. EBITDA $530M-$540M Vs Prior Guidance Of $575M
Express News | Scotts Miracle-Gro Co: Expects to Reduce Leverage to Below 5 Times Ebitda by Fiscal Year-End
Express News | Scotts Miracle-Gro Co: Sees Mid Single-Digit Growth in Core Consumer Business Versus Prior Year
Scotts Miracle-Gro Sees FY24 U.S. Consumer Segment Sales Growth of 5%-7% >SMG
Scotts Miracle-Gro Sees FY24 U.S. Consumer Segment Sales Growth of 5%-7% >SMG
ScottsMiracle-Gro Updates Fiscal '24 Guidance at Peak of Lawn and Garden Season
Reaffirms two-year free cash flow target of $1 billion, debt paydown of $350 million in fiscal '24 and full-year non-GAAP gross margin improvement of 250 bpsExpects to reduce leverage to below 5 times
Express News | NYSE Order Imbalance 54684.0 Shares on Sell Side
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 3, 2024
GAINERS:1933 Industries (OTC:TGIFF) shares closed up 31.87% at $0.01CV Sciences (OTC:CVSI) shares closed up 17.65% at $0.08Eastside Distilling (NASDAQ:EAST) shares closed up 9.80% at $1.04Corbus Pharm
Express News | NYSE Order Imbalance 55028.0 Shares on Buy Side
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results.SAIC reported a 9% revenue decline year over year in the fiscal first qua
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Week of 6/2/24
Cannabis Stock Gainers And Losers From May 31, 2024
GAINERS:Blueberries Medical (OTC:BBRRF) shares closed up 44.66% at $0.01Target Group (OTC:CBDY) shares closed up 21.43% at $0.00Cara Therapeutics (NASDAQ:CARA) shares closed up 8.61% at $0.65CV Scienc
This Cannabis Merger Will Cover 25% Of U.S. Population: Cansortium & RIV Capital Powered By ScottsMiracle-Gro
Cansortium Inc. (OTC:CNTMF), a multi-state cannabis operator under the FLUENT brand and RIV Capital Inc. (OTC:CNPOF) announced a merger that will operate in Florida, New York, Texas, and Pennsylvania,
Express News | Scottsmiracle-Gro Poised to Advance Cannabis Strategy in New York, Florida and Other States